You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

DETROL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Detrol patents expire, and what generic alternatives are available?

Detrol is a drug marketed by Upjohn and is included in two NDAs.

The generic ingredient in DETROL is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Detrol

A generic version of DETROL was approved as tolterodine tartrate by IVAX SUB TEVA PHARMS on February 23rd, 2015.

  Try a Trial

Drug patent expirations by year for DETROL
Drug Prices for DETROL

See drug prices for DETROL

Recent Clinical Trials for DETROL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, San FranciscoPhase 4
Astellas Scientific & Medical Affairs, Inc.
Astellas Pharma Global Development, Inc.Phase 4

See all DETROL clinical trials

Pharmacology for DETROL

US Patents and Regulatory Information for DETROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-001 Mar 25, 1998 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-002 Mar 25, 1998 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DETROL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-001 Mar 25, 1998 ⤷  Try a Trial ⤷  Try a Trial
Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-001 Mar 25, 1998 ⤷  Try a Trial ⤷  Try a Trial
Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-002 Mar 25, 1998 ⤷  Try a Trial ⤷  Try a Trial
Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-002 Mar 25, 1998 ⤷  Try a Trial ⤷  Try a Trial
Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-002 Mar 25, 1998 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for DETROL

See the table below for patents covering DETROL around the world.

Country Patent Number Title Estimated Expiration
Norway 305477 ⤷  Try a Trial
Hungary 891069 ⤷  Try a Trial
European Patent Office 0774467 Procédé de redistribution de trichlorosilane (Method for redistribution of trichlorosilane) ⤷  Try a Trial
Japan H03503163 ⤷  Try a Trial
Hungary 9501329 ⤷  Try a Trial
Germany 68900180 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for DETROL

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0325571 C980020 Netherlands ⤷  Try a Trial PRODUCT NAME: TOLTERODINE, DESGEWENST IN DE VORM VAN EEN ZOUT MET EEN FYSIOLO GISCH ACCEPTABEL ZUUR, IN HET BIJZONDER TOLTERODINE L-TARTRAAT; NAT. REGISTRATION NO/DATE: RVG 22148, RVG 22149 19980217; FIRST REGISTRATION: SE 13475, 13476 19970905
0325571 1998C0031 Belgium ⤷  Try a Trial PRODUCT NAME: TOLTERODINI-L-TARTRAS (=TOLTERODINUM); NATL REGISTRATION NO/DATE: 277 IS 301 F 3 19980309; FIRST REGISTRATION: SE 13475 19970905
0325571 21/1998 Austria ⤷  Try a Trial PRODUCT NAME: TOLTERODIN, SEINE SALZE, RACEMATE UND ENANTIOMERE; NAT. REGISTRATION NO/DATE: 1-22389 UND 1-22390 19980210; FIRST REGISTRATION: SE 13475 UND 13476 19970905
0325571 SPC/GB98/027 United Kingdom ⤷  Try a Trial PRODUCT NAME: TOLTERODINE OPTIONALLY IN THE FORM OF PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: SE 13475 19970905; SE 13476 19970905; UK 00032/0222 19980203; UK 00032/0223 19980203
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.